These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12192597)

  • 1. IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.
    Mintz A; Gibo DM; Slagle-Webb B; Christensen ND; Debinski W
    Neoplasia; 2002; 4(5):388-99. PubMed ID: 12192597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway.
    Kawakami K; Taguchi J; Murata T; Puri RK
    Blood; 2001 May; 97(9):2673-9. PubMed ID: 11313257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin.
    Joshi BH; Kawakami K; Leland P; Puri RK
    Clin Cancer Res; 2002 Jun; 8(6):1948-56. PubMed ID: 12060640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer.
    Kawakami K; Kawakami M; Joshi BH; Puri RK
    Cancer Res; 2001 Aug; 61(16):6194-200. PubMed ID: 11507072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain.
    Kawakami K; Takeshita F; Puri RK
    J Biol Chem; 2001 Jul; 276(27):25114-20. PubMed ID: 11352909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma.
    Mintz A; Gibo DM; Madhankumar AB; Debinski W
    J Neurooncol; 2003; 64(1-2):117-23. PubMed ID: 12952292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways.
    David M; Ford D; Bertoglio J; Maizel AL; Pierre J
    Oncogene; 2001 Oct; 20(46):6660-8. PubMed ID: 11709700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
    Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
    Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.
    Debinski W; Obiri NI; Powers SK; Pastan I; Puri RK
    Clin Cancer Res; 1995 Nov; 1(11):1253-8. PubMed ID: 9815919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts.
    Kawakami K; Husain SR; Bright RK; Puri RK
    Cancer Gene Ther; 2001 Nov; 8(11):861-8. PubMed ID: 11773976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation and functional analysis of IL-13 receptors in human malignant glioma cells.
    Kawakami M; Leland P; Kawakami K; Puri RK
    Oncol Res; 2001; 12(11-12):459-67. PubMed ID: 11939409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling.
    Daines MO; Tabata Y; Walker BA; Chen W; Warrier MR; Basu S; Hershey GK
    J Immunol; 2006 Jun; 176(12):7495-501. PubMed ID: 16751396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of IL-13 receptor alpha2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression.
    David MD; Bertoglio J; Pierre J
    Oncogene; 2003 May; 22(22):3386-94. PubMed ID: 12776189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma.
    Daines MO; Hershey GK
    J Biol Chem; 2002 Mar; 277(12):10387-93. PubMed ID: 11786536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain.
    Schnyder B; Lugli S; Feng N; Etter H; Lutz RA; Ryffel B; Sugamura K; Wunderli-Allenspach H; Moser R
    Blood; 1996 May; 87(10):4286-95. PubMed ID: 8639787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen.
    Shimato S; Natsume A; Wakabayashi T; Tsujimura K; Nakahara N; Ishii J; Ito M; Akatsuka Y; Kuzushima K; Yoshida J
    J Neurosurg; 2008 Jul; 109(1):117-22. PubMed ID: 18590440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of the rat IL-13 alpha 2 receptor cDNA and its expression in rat tissues.
    Wu AH; Low WC
    J Neurooncol; 2002 Sep; 59(2):99-105. PubMed ID: 12241113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease.
    Kawakami K; Kawakami M; Puri RK
    Mol Cancer Ther; 2004 Feb; 3(2):137-47. PubMed ID: 14985454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
    Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
    J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral vector-mediated gene transfer of IL-13Ralpha2 chain followed by IL-13 cytotoxin treatment offers potent targeted therapy for cytotoxin-resistant cancers.
    Saito M; Murata T; Watanabe K; Kawakami K; Suzuki M; Koji T; Puri RK; Kitazato K; Kobayashi N
    Int J Cancer; 2005 Aug; 116(1):1-8. PubMed ID: 15756691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.